|
시장보고서
상품코드
1967842
핵산 분리 및 정제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Nucleic Acid Isolation & Purification Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
핵산 분리·정제 시장 규모는 2025년 63억 8,000만 달러에서 2026-2034년에 CAGR 8.21%로 성장하며, 2034년에는 129억 9,000만 달러에 달할 것으로 예측되고 있습니다.
분자진단, 유전체 연구, 맞춤의료 증가로 인해 세계 핵산 분리 및 정제 시장은 크게 확대되고 있습니다. 이러한 기술은 PCR, 시퀀싱, 클로닝과 같은 다운스트림 공정을 위해 생물학적 샘플에서 DNA와 RNA를 추출하는 데 필수적입니다. COVID-19 팬데믹은 신뢰할 수 있는 추출 키트, 자동화 시스템, 마그네틱 비드 기반 정제 방법에 대한 수요를 가속화하여 전 세계 실험실 인프라를 강화했습니다.
주요 성장 요인으로는 차세대 염기서열분석(NGS)의 보급 확대, 감염성 및 유전성 질환 증가, 생명공학 및 제약 분야의 연구개발 확대 등을 꼽을 수 있습니다. 자동화 및 하이스루풋 플랫폼의 도입으로 임상 및 실험실의 효율성과 재현성이 향상되었습니다. 유전체학 프로젝트에 대한 정부 자금 지원과 시료 준비 기술의 발전은 학술, 진단 및 산업 분야 전반에 걸쳐 시장 성장을 더욱 촉진하고 있습니다.
정밀의료, 액체생검, 유전자 치료 개발의 지속적인 수요로 인해 미래 전망은 유망합니다. 특히 현장진단에서 소형화, 신속화, 자동화된 추출 솔루션이 보급될 것으로 예측됩니다. 분자 검사 역량에 투자하는 신흥 국가들이 새로운 기회를 창출할 것입니다. 다만, 비용 민감도와 표준화된 프로토콜의 필요성이 경쟁 환경에 영향을 미칠 수 있습니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 핵산 분리·정제 시장 : 제품별
제5장 세계의 핵산 분리·정제 시장 : 유형별
제6장 세계의 핵산 분리·정제 시장 : 방법별
제7장 세계의 핵산 분리·정제 시장 : 용도별
제8장 세계의 핵산 분리·정제 시장 : 최종 사용별
제9장 세계의 핵산 분리·정제 시장 : 지역별
제10장 경쟁 구도
제11장 기업 개요
KSA 26.03.24The Nucleic Acid Isolation & Purification Market size is expected to reach USD 12.99 Billion in 2034 from USD 6.38 Billion (2025) growing at a CAGR of 8.21% during 2026-2034.
The global nucleic acid isolation and purification market has expanded significantly due to rising molecular diagnostics, genomics research, and personalized medicine initiatives. These technologies are essential for extracting DNA and RNA from biological samples for downstream applications such as PCR, sequencing, and cloning. The COVID-19 pandemic accelerated demand for reliable extraction kits, automation systems, and magnetic bead-based purification methods, strengthening laboratory infrastructure worldwide.
Key drivers include growing adoption of next-generation sequencing (NGS), increasing prevalence of infectious and genetic diseases, and expansion of biotech and pharmaceutical R&D. Automation and high-throughput platforms have improved efficiency and reproducibility in clinical and research laboratories. Government funding for genomics projects and advancements in sample preparation technologies further stimulate market growth across academic, diagnostic, and industrial sectors.
Future prospects are promising, with sustained demand from precision medicine, liquid biopsy, and gene therapy development. Miniaturized, rapid, and automated extraction solutions will gain traction, especially in point-of-care diagnostics. Emerging economies investing in molecular testing capacity will create additional opportunities. However, cost sensitivity and the need for standardized protocols may influence competitive dynamics.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Reagents & Kits
- Instruments
By Type
- Rna Isolation & Purification
- Mrna Isolation & Purification
- Mirna Isolation & Purification
- Total Rna Isolation & Purification
- Other Rna Isolation & Purification Types
- Dna Isolation & Purification
- Genomic Dna Isolation & Purification
- Plasmid Dna Isolation & Purification
- Viral Dna Isolation & Purification
- Other Dna Isolation & Purification Types
By Method
- Magnetic Beads
- Column-Based
- Reagent-Based
- Other Methods
By Application
- Diagnostics
- Drug Discovery & Development
- Precision Medicine
- Other Applications
By End-Use
- Hospitals And Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Other End-Users
COMPANIES PROFILED
- Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corporation, F Hoffmann La Roche Ltd, Merck KGaA, Agilent Technologies Inc, BioRad Laboratories, Takara Bio Inc, Promega Corporation, New England Biolabs, Abcam plc, PCR Biosystems
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY TYPE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Type
- 5.2. Rna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Mrna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Mirna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Total Rna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Other Rna Isolation & Purification Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.8. Genomic Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.9. Plasmid Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.10. Viral Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.11. Other Dna Isolation & Purification Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY METHOD 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Method
- 6.2. Magnetic Beads Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Column-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Reagent-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Other Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY APPLICATION 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast Application
- 7.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Precision Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY END-USE 2022-2034 (USD MN)
- 8.1. Market Analysis, Insights and Forecast End-use
- 8.2. Hospitals And Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 8.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY REGION 2022-2034(USD MN)
- 9.1. Regional Outlook
- 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.2.1 By Product
- 9.2.2 By Type
- 9.2.3 By Method
- 9.2.4 By Application
- 9.2.5 By End-use
- 9.2.6 United States
- 9.2.7 Canada
- 9.2.8 Mexico
- 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.3.1 By Product
- 9.3.2 By Type
- 9.3.3 By Method
- 9.3.4 By Application
- 9.3.5 By End-use
- 9.3.6 United Kingdom
- 9.3.7 France
- 9.3.8 Germany
- 9.3.9 Italy
- 9.3.10 Russia
- 9.3.11 Rest Of Europe
- 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.4.1 By Product
- 9.4.2 By Type
- 9.4.3 By Method
- 9.4.4 By Application
- 9.4.5 By End-use
- 9.4.6 India
- 9.4.7 Japan
- 9.4.8 South Korea
- 9.4.9 Australia
- 9.4.10 South East Asia
- 9.4.11 Rest Of Asia Pacific
- 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.5.1 By Product
- 9.5.2 By Type
- 9.5.3 By Method
- 9.5.4 By Application
- 9.5.5 By End-use
- 9.5.6 Brazil
- 9.5.7 Argentina
- 9.5.8 Peru
- 9.5.9 Chile
- 9.5.10 South East Asia
- 9.5.11 Rest of Latin America
- 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.6.1 By Product
- 9.6.2 By Type
- 9.6.3 By Method
- 9.6.4 By Application
- 9.6.5 By End-use
- 9.6.6 Saudi Arabia
- 9.6.7 UAE
- 9.6.8 Israel
- 9.6.9 South Africa
- 9.6.10 Rest of the Middle East And Africa
Chapter 10. COMPETITIVE LANDSCAPE
- 10.1. Recent Developments
- 10.2. Company Categorization
- 10.3. Supply Chain & Channel Partners (based on availability)
- 10.4. Market Share & Positioning Analysis (based on availability)
- 10.5. Vendor Landscape (based on availability)
- 10.6. Strategy Mapping
Chapter 11. COMPANY PROFILES OF GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION INDUSTRY
- 11.1. Top Companies Market Share Analysis
- 11.2. Company Profiles
- 11.2.1 Qiagen N.V
- 11.2.2 Thermo Fisher Scientific Inc
- 11.2.3 Illumina Inc
- 11.2.4 Danaher Corporation
- 11.2.5 F. Hoffmann La Roche Ltd
- 11.2.6 Merck KGaA
- 11.2.7 Agilent Technologies Inc
- 11.2.8 Bio-Rad Laboratories
- 11.2.9 Takara Bio Inc
- 11.2.10 Promega Corporation
- 11.2.11 New England Biolabs
- 11.2.12 Abcam Plc
- 11.2.13 PCR Biosystems
